Acute Cholecystitis Clinical Trial
— MRCOfficial title:
Accuracy of Functional MRC With Gadoxetate Disodium in the Diagnosis of Acute Cholecystitis: Comparison With Hepatobiliary Scintigraphy
Verified date | May 2017 |
Source | University of California, Davis |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Functional magnetic resonance cholangiography (fMRC) with gadoxetate disodium (Eovist) is an accurate method of diagnosing acute cholecystitis.
Status | Completed |
Enrollment | 17 |
Est. completion date | April 2016 |
Est. primary completion date | April 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - 18 years of age or older - Symptoms of right upper quadrant pain with ambiguous US (and/or CT) findings - Standard of care nuclear medicine hepatobiliary scan to rule out acute cholecystitis - Exclusion Criteria: - Scheduled for emergent surgery, or is otherwise determined by the Investigator that the subject is clinically unsuitable for the study - Glomerular filtration rate (GFR) below 60 mL/min/1.73m2 - Total bilirubin above 3.0 mg/dL - Inability to provide informed consent (altered or diminished mental status) - Allergic to morphine - Known or suspected hypersensitivity to gadolinium-based agents - The standard MRI contraindications apply, including but not limited to: having a pacemaker or other implanted electronic device, metal foreign bodies within the eye, aneurysm clips, heart valve prosthesis, vascular stents, coils, intrauterine devices (IUDs), penile implants, inferior vena cava (IVC) filters, gunshot wounds with retained bullet fragments. - Pregnant or breast-feeding - |
Country | Name | City | State |
---|---|---|---|
United States | UC Davis Medical Center | Sacramento | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Davis |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of positive cases of acute cholecystitis | The primary outcome measure is the number of positive cases of acute cholecystitis on functional magnetic resonance imaging | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04156711 -
Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery
|
N/A | |
Recruiting |
NCT02130245 -
Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study
|
N/A | |
Completed |
NCT01942356 -
Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor
|
N/A | |
Completed |
NCT04995380 -
Validation and Comparison of Scores for Prediction of RIsk for Post-operative Major Morbidity After Cholecystectomy in Acute Calculous Cholecystitis (SPRIMACC)
|
||
Completed |
NCT03999645 -
Is it Safe to do Laparoscopic Cholecystectomy for Acute Cholecystitis up to Seven Days?
|
N/A | |
Completed |
NCT03296280 -
Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
|
||
Completed |
NCT03002051 -
EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent
|
N/A | |
Completed |
NCT00447304 -
Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy
|
Phase 3 | |
Completed |
NCT04346550 -
Comparison of Morbidity After Laparoscopic Cholecystectomy for Acutely Inflamed Gall Bladder With and Without Drain
|
N/A | |
Active, not recruiting |
NCT04197908 -
EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study.
|
N/A | |
Completed |
NCT02027402 -
Effects of Drainage in Laparoscopic Cholecystectomy
|
N/A | |
Not yet recruiting |
NCT01706068 -
Transient ECG Changes in Patients With Acute Biliary Disease
|
N/A | |
Enrolling by invitation |
NCT04633512 -
Safety and Feasibility of ActivSightTM in Human
|
N/A | |
Completed |
NCT04672902 -
Treatment of Mirizzi Syndrome
|
||
Completed |
NCT03122054 -
Early Versus Delayed Cholecystectomy
|
N/A | |
Recruiting |
NCT05732480 -
Influence of Gut Microbiome in Gallstone Disease
|
||
Completed |
NCT04308265 -
Scoring System in Acute Calculous Cholecystitis
|
||
Not yet recruiting |
NCT06287112 -
Prevention of Acute Cholecystitis With ETGBD
|
N/A | |
Recruiting |
NCT05709548 -
Use of Indocyanine Green in Acute Cholecystitis
|
Phase 4 | |
Not yet recruiting |
NCT06459323 -
the Outcomes of Laparoscopic Cholecystectomy for Acute Cholecystitis Within and Beyond the First 72 Hours, Does it Differ?!
|
N/A |